EyeContact Dx
Clinical Co-Pilot for ASD Care
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in April 2022 by Aryeh Taub and Hovav Dror, EyeContact Dx operates with 11–50 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.
Business overview
EyeContact Dx is a Health Tech & Life Sciences company specializing in Digital Medical Diagnostics within the Digital Healthcare sector. The company develops software designed to detect autism spectrum disorders (ASD) in toddlers. Its core product is an eye-tracking-based screener, engineered for seamless integration and to provide fast, reliable results. EyeContact Dx partners with pediatric clinics to deliver advanced, accessible solutions for early ASD care, serving the healthcare provider market.
Company Intelligence Q&A
- What is EyeContact Dx's primary focus?
- EyeContact Dx is focused on developing software for the early detection of autism spectrum disorders (ASD) in toddlers, aiming to provide advanced and accessible solutions for pediatric care.
- When was EyeContact Dx founded?
- EyeContact Dx was founded in April 2022 by Aryeh Taub and Hovav Dror.
- What is EyeContact Dx's main product?
- The company's first product is an eye-tracking-based screener designed for seamless integration into clinical settings and to deliver fast, reliable results for ASD detection.
- Which market does EyeContact Dx primarily serve?
- EyeContact Dx primarily serves the healthcare market, specifically partnering with pediatric clinics to implement its diagnostic solutions.
- What is the current employee size of EyeContact Dx?
- EyeContact Dx currently has 11–50 employees.